AW
Insider
Amir Weiss
Chief Accounting OfficerAmir Weiss (Chief Accounting Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $384K of TEVA (10,679 sh × $36.00, as filed), executed May 6.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Aug 21
Filed Aug 25
Median ADV $196.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
TEVARecent filings
TEVASALE
Teva Pharmaceutical Industries Limited
View filing →
$261K6,945 sh × $37.61
Exec Aug 21
Filed Aug 25 · 4:05 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $384K
10,679 sh × $36.00
Exec May 6
Filed May 7 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $371K
12,300 sh × $30.20
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $301K
12,300 sh × $24.44
Exec Nov 6 2025
Filed Nov 10 2025 · 5:30 PM ET